Literature DB >> 10488818

Oculoleptomeningeal amyloidosis associated with a new transthyretin variant Ser64.

T Uemichi1, R J Uitti, A H Koeppen, J R Donat, M D Benson.   

Abstract

BACKGROUND: A Canadian family with oculoleptomeningeal amyloidosis with both central and peripheral nervous system disorders was described in 1988. Death of affected family members resulted from recurrent cerebral hemorrhage.
OBJECTIVE: To determine if oculoleptomeningeal amyloidosis is caused by a mutation in transthyretin (prealbumin).
METHODS: DNA isolated from peripheral blood and archival tissues of affected members of the kindred was studied by direct DNA sequencing and restriction fragment length polymorphism analysis.
RESULTS: Direct DNA sequencing identified a thymine-to-cytosine transition at the second base of codon 64, which resulted in a replacement of serine for phenylalanine. This mutation, which creates an additional HinfI site was detected by restriction fragment length polymorphism analysis in each affected individual.
CONCLUSION: In this kindred, oculoleptomeningeal amyloidosis is related to a mutation in transthyretin (Phe64Ser).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10488818     DOI: 10.1001/archneur.56.9.1152

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  13 in total

Review 1.  Amyloid neuropathies.

Authors:  Susan C Shin; Jessica Robinson-Papp
Journal:  Mt Sinai J Med       Date:  2012 Nov-Dec

2.  The identification of a transthyretin variant p.D38G in a Chinese family with early-onset leptomeningeal amyloidosis.

Authors:  Kuan Fan; Haixia Zhu; Hongbo Xu; Ping Mao; Lamei Yuan; Hao Deng
Journal:  J Neurol       Date:  2018-11-23       Impact factor: 4.849

3.  THAOS: gastrointestinal manifestations of transthyretin amyloidosis - common complications of a rare disease.

Authors:  Jonas Wixner; Rajiv Mundayat; Onur N Karayal; Intissar Anan; Pontus Karling; Ole B Suhr
Journal:  Orphanet J Rare Dis       Date:  2014-04-27       Impact factor: 4.123

4.  Intracranial and systemic manifestations of familial leptomeningeal amyloidosis, as seen on CT and MRI.

Authors:  Saralyn Beckius; Kamran Shah
Journal:  Radiol Case Rep       Date:  2018-09-13

Review 5.  The Amyloid-Tau-Neuroinflammation Axis in the Context of Cerebral Amyloid Angiopathy.

Authors:  Pablo Cisternas; Xavier Taylor; Cristian A Lasagna-Reeves
Journal:  Int J Mol Sci       Date:  2019-12-14       Impact factor: 5.923

Review 6.  Current Review of Leptomeningeal Amyloidosis Associated With Transthyretin Mutations.

Authors:  Qi Qin; Cuibai Wei; YueShan Piao; Fang Lian; Hao Wu; Aihong Zhou; Fen Wang; Xiumei Zuo; Yue Han; Jihui Lyu; Dongmei Guo; Jianping Jia
Journal:  Neurologist       Date:  2021-09-07       Impact factor: 1.398

7.  Neuropathologic analysis of Tyr69His TTR variant meningovascular amyloidosis with dementia.

Authors:  Jennifer L Ziskin; Michael D Greicius; Wan Zhu; Anna N Okumu; Christopher M Adams; Edward D Plowey
Journal:  Acta Neuropathol Commun       Date:  2015-07-10       Impact factor: 7.801

8.  Oculoleptomeningeal Amyloidosis associated with transthyretin Leu12Pro in an African patient.

Authors:  P McColgan; S Viegas; S Gandhi; K Bull; R Tudor; F Sheikh; J Pinney; M Fontana; D Rowczenio; J D Gillmore; J A Gilbertson; C J Whelan; S Shah; Z Jaunmuktane; J L Holton; J M Schott; D J Werring; P N Hawkins; M M Reilly
Journal:  J Neurol       Date:  2014-12-09       Impact factor: 4.849

Review 9.  Transthyretin Amyloidosis: Update on the Clinical Spectrum, Pathogenesis, and Disease-Modifying Therapies.

Authors:  Haruki Koike; Masahisa Katsuno
Journal:  Neurol Ther       Date:  2020-09-18

Review 10.  Ocular Involvement in Hereditary Amyloidosis.

Authors:  Angelo Maria Minnella; Roberta Rissotto; Elena Antoniazzi; Marco Di Girolamo; Marco Luigetti; Martina Maceroni; Daniela Bacherini; Benedetto Falsini; Stanislao Rizzo; Laura Obici
Journal:  Genes (Basel)       Date:  2021-06-22       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.